Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2021-09-08
Target enrollment:
Participant gender:
Summary
This study is a phase 3, randomized, double blind and vehicle study to evaluate the efficacy
and safety of Crisaborole ointment, 2% in Chinese and Japanese subjects with mild to moderate
atopic dermatitis involving at least 5% treatable BSA. Eligible subjects will be randomized
in a 2:1 ratio to one of 2 treatment groups (Crisaborole BID, Vehicle BID, respectively).